NexImmune, Inc.
NEXIDelisted Sep 6, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001538210
NexImmune, Inc. was delisted on Sep 6, 2024; its insiders filed their last Form 4 on Jun 13, 2024; 13 institutions reported holding it in 13F filings for Q2 2024, worth $408.6K in total; no superinvestor held it.
13F holders, Q1 2023
Institutional positions in NexImmune, Inc. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 31
- +2 vs. Q4 2022
- Shares held
- 5.78M
- −181.2K (−3.0%) vs. Q4 2022
- Total value
- $2.20M
- +$748.3K (+51.6%) vs. Q4 2022
- New holders
- 7
- 8 more added
- Sold out
- 5
- 6 more reduced
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting NEXI on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 1 | $2.70K |
| Q2 2024 | 13 | $408.6K |
| Q1 2024 | 12 | $858.3K |
| Q4 2023 | 11 | $229.4K |
| Q3 2023 | 31 | $921.4K |
| Q2 2023 | 32 | $1.26M |
| Q1 2023 | 31 | $2.20M |
| Q4 2022 | 29 | $1.45M |
| Q3 2022 | 39 | $4.34M |
| Q2 2022 | 46 | $13.4M |
| Q1 2022 | 52 | $40.1M |
| Q4 2021 | 46 | $47.1M |
| Q3 2021 | 47 | $160.3M |
| Q2 2021 | 42 | $119.0M |
| Q1 2021 | 46 | $184.9M |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding NexImmune, Inc.; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| UBS Group AG | 49 | $19 | 0.00% | −16,573−99.7% | Reduced |
| Wells Fargo & Company | 133 | $51 | 0.00% | +11+9.0% | Added |
| Advisor Group Holdings, Inc. | 250 | $95 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 387 | $147 | 0.00% | +341+741.3% | Added |
| Tower Research Capital LLC (TRC) | 6,515 | $2.00K | 0.00% | −19−0.3% | Reduced |
| Smith, Salley & Associates | 10,000 | $3.80K | 0.00% | −1,000−9.1% | Reduced |
| Northern Trust Corp | 12,668 | $4.81K | 0.00% | 00.0% | Unchanged |
| Davenport & Co LLC | 18,000 | $6.84K | 0.00% | +7,500+71.4% | Added |
| BBR Partners, LLC | 20,000 | $7.60K | 0.00% | +20,000 | New |
| State Street Corp | 22,919 | $8.71K | 0.00% | 00.0% | Unchanged |
| Baader Bank INC | 29,640 | $8.79K | 0.00% | +29,640 | New |
| Sawtooth Solutions, LLC | 24,700 | $9.39K | 0.00% | +24,700 | New |
| Two Sigma Investments, LP | 38,649 | $14.7K | 0.00% | +38,649 | New |
| Renaissance Technologies LLC | 39,400 | $15.0K | 0.00% | −250,300−86.4% | Reduced |
| BlackRock Inc. | 43,868 | $16.7K | 0.00% | +1,398+3.3% | Added |
| Bank of Montreal | 32,000 | $18.9K | 0.00% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 50,000 | $19.0K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 61,732 | $23.5K | 0.00% | −1,224−1.9% | Reduced |
| Envestnet Asset Management Inc | 81,421 | $30.9K | 0.00% | +81,421 | New |
| CAPROCK Group, Inc. | 103,482 | $39.3K | 0.00% | +46,900+82.9% | Added |
| M28 Capital Management LP | 133,442 | $50.7K | 0.06% | 00.0% | Unchanged |
| First Manhattan Co | 149,110 | $56.7K | 0.00% | +124,110+496.4% | Added |
| Millennium Management LLC | 236,521 | $90.0K | 0.00% | −269,131−53.2% | Reduced |
| The PNC Financial Services Group, Inc. | 316,039 | $120.1K | 0.00% | +148,602+88.8% | Added |
| Raymond James & Associates | 320,622 | $121.8K | 0.00% | +290,000+947.0% | Added |
| EPIQ Capital Group, LLC | 390,600 | $148.4K | 0.08% | 00.0% | Unchanged |
| Vanguard Group Inc | 473,977 | $180.1K | 0.00% | 00.0% | Unchanged |
| Allen Operations LLC | 635,934 | $241.7K | 0.06% | 00.0% | Unchanged |
| Citigroup Inc | 799,170 | $303.7K | 0.00% | +799,170 | New |
| Adage Capital Partners GP, L.L.C. | 801,371 | $304.5K | 0.00% | 00.0% | Unchanged |
| Slate Path Capital LP | 925,000 | $351.5K | 0.02% | +925,000 | New |
| Artal Group S.A. | 0 | $0 | 0.00% | −1,200,000−100.0% | Sold out |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −925,945−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −42,740−100.0% | Sold out |
| ArrowMark Colorado Holdings LLC | 0 | $0 | 0.00% | −10,924−100.0% | Sold out |
| Morgan Stanley | 0 | $0 | 0.00% | −815−100.0% | Sold out |